Sep 29, 2023

Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer | Faculty Presentation 2: Current and Future Role of Nonbiomarker-Based Strategies for Patients with Metastatic BRCA-Negative TNBC — Hope S Rugo, MD

CME information and select...

Sep 29, 2023

Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer | Faculty Presentation 1: Biomarker-Based Decision-Making for Patients with Metastatic BRCA-Negative, Triple-Negative Breast Cancer (TNBC) — Tiffany A Traina, MD, FASCO

CME information and select...

Sep 29, 2023

Featuring perspectives from Dr Hope S Rugo and Dr Tiffany Traina, including the following topics:

• Introduction: “Isn’t Oncology Depressing?” (0:00)
• Checkpoint Inhibitors (13:37)
• Antibody-Drug Conjugates (30:04)
• HER2-Low Disease (54:25)
• Other Agents Under Development (59:54)

CME information and select...

Aug 24, 2023

Featuring perspectives from Dr Adiyta Bardia and Dr Erika Hamilton, including the following topics:

• Introduction: Biopharmacology and Endocrinology of Breast Cancer (0:00)
• Current Strategies for Previously Treated ER-Positive Metastatic Breast Cancer (mBC) — Dr Bardia (12:15)
• Future Directions in the Management...

Aug 24, 2023

Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor | Faculty Presentation 2: Future Directions in the Management of ER-Positive mBC — Erika Hamilton, MD

CME information and select...